Objective-Rho/Rho-kinase (ROCK) pathway in vascular smooth muscle cells (VSMCs) plays an important role in the pathogenesis of cardiovascular diseases, including pulmonary arterial hypertension (PAH). Rho-kinase has 2 isoforms, ROCK1 and ROCK2, with different functions in different cells; ROCK1 for circulating inflammatory cells and ROCK2 for the vasculature. In the present study, we aimed to examine whether ROCK2 in VSMC is involved in the pathogenesis of PAH. Approach and Results-In patients with PAH, the expression of ROCK2 was increased in pulmonary arterial media and primary pulmonary arterial smooth muscle cells when compared with controls. To investigate the role of ROCK2 in VSMC, we generated VSMC-specific heterozygous ROCK2-deficient (ROCK2 +/− ) mice and VSMC-specific ROCK2overexpressing transgenic (ROCK2-Tg) mice. The extent of hypoxia-induced pulmonary hypertension was reduced in ROCK2 +/− mice and was enhanced in ROCK2-Tg mice compared with respective littermates. The protein expression of ROCK activity and phosphorylated extracellular signal-regulated kinase and the number of Ki67-positive proliferating cells in the lung were reduced in ROCK2 +/− mice and were increased in ROCK2-Tg mice compared with respective littermates. In cultured mouse aortic VSMC, migration and proliferation activities were reduced in ROCK2 +/− mice, and migration activity was increased in ROCK2-Tg mice compared with respective littermates. In addition, in primary pulmonary arterial smooth muscle cells from a patient with PAH, ROCK2 was required for migration and proliferation through ROCK and extracellular signal-regulated kinase activation. Conclusions-ROCK2 in VSMC contributes to the pathogenesis of PAH. (Arterioscler Thromb Vasc Biol. 2013;33:2780-2791.) 
P ulmonary arterial hypertension (PAH) is a fatal disease characterized by increased pulmonary vascular resistance, leading to right heart failure and death. 1, 2 Increased pulmonary vascular resistance is caused by distal pulmonary vascular remodeling, including prolonged vasoconstriction, proliferation and migration of vascular smooth muscle cells (VSMCs), and endothelial injury. 3 Although multiple pharmacological agents, such as vasodilators and anticoagulants, have been developed for the treatment of PAH, long-term prognosis of patients with severe PAH remains poor because of progressive right heart failure. 3 Thus, more effective treatments need to be urgently developed.
Rho-kinase (ROCK) belongs to the serine/threonine kinases family and is an important downstream effector of the small GTP-binding protein RhoA. It has been demonstrated that Rho/ROCK pathway plays an important role in various fundamental cellular functions, including contraction, motility, proliferation, and migration, leading to the development of cardiovascular diseases, including PAH. 4, 5 There are 2 isoforms of ROCK: ROCK1 (Rho-kinase β) and ROCK2 (Rho-kinase α). 6 ROCK1 and ROCK2 are highly homologous, sharing 65% homology in amino acid sequence and 92% homology in their kinase domains. 6 Both isoforms are ubiquitously expressed in invertebrates and vertebrates with ROCK1 expressed mainly in circulating inflammatory cells and ROCK2 in VSMC. 7, 8 Homozygous ROCK1-deficient mice show open eyelids at birth and omphalocele, whereas homozygous ROCK2-deficient mice die embryonically because of placental dysfunction, 9, 10 suggesting that ROCK1 and ROCK2 mediate different functions in different types of cells.
We have previously reported that a long-term treatment with an isoform-nonspecific ROCK inhibitor, fasudil, suppresses the development of monocrotaline-induced and hypoxia-induced pulmonary hypertension (PH) in animal models. 11, 12 Furthermore, we have recently obtained a direct evidence for increased ROCK activation in patients with idiopathic PAH (IPAH). 13 However, although isoform-nonspecific ROCK inhibitors were effective in previous studies of PAH in both animals and humans, 14 the particular isoform of ROCK responsible for the effect has not been evaluated.
It was previously reported that heterozygous ROCK1deficient mice had decreased neointima formation after carotid artery ligation associated with reduced leukocytemediated inflammation. 15 Thus, ROCK1 seems to play an important role in circulating inflammatory cells in the pathogenesis of vascular diseases. 7, 8 In contrast, Rho/ROCK2 pathway plays a central role in VSMC-mediated vasoconstriction that promotes PAH, where ROCK2 predominantly regulates VSMC contractility when compared with ROCK1, by directly binding to and phosphorylating the myosin-binding subunit of myosin phosphatase. 16 However, the role of ROCK2 remains largely unknown in the pathogenesis of PAH characterized by increased vasoconstriction, proliferation, and migration of VSMC. Furthermore, no study has ever used genetically modified mouse models to identify the role of ROCK2 in PAH. In the present study, we thus developed VSMC-specific heterozygous ROCK2-deficient (ROCK2 +/− ) mice using the Cre-loxP system and VSMC-specific ROCK2-overexpressing transgenic (ROCK2-Tg) mice under the control of SM22α promoter ( Figure IA -IC in the online-only Data Supplement) and adopted a mouse model of hypoxia-induced PH. 17 Using these mouse models, we tested our hypothesis; when compared with ROCK1, ROCK2 in VSMC contributes to the pathogenesis of PAH through enhanced VSMC migration and proliferation.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Upregulation of ROCK2 in the Media of Pulmonary Arteries and PASMC From Patients With IPAH
First, we examined whether the expression of ROCK2 is upregulated in lung tissues and pulmonary arterial smooth muscle cells (PASMCs) from patients with IPAH. Immunostaining of ROCKs showed that immunoreactivity of ROCK2, but not that of ROCK1, was enhanced in the pulmonary arteries from patients with IPAH compared with controls ( Figure 1A ). Furthermore, the enhanced expression of ROCK2 was colocalized with α-smooth muscle actin-positive pulmonary arterial media composed of PASMC ( Figure 1A ). The number of proliferating and inflammatory cells coexpressing phosphorylated form of extracellular signal-regulated kinase 1/2 (P-ERK 1/2), Ki67, and CD45 was also markedly increased around the pulmonary arteries from patients with IPAH ( Figure II in the online-only Data Supplement). Reverse transcriptase-polymerase chain reaction also showed the upregulation of ROCK2, but not ROCK1, in PASMC from pulmonary arteries of IPAH patients as compared with controls ( Figure 1B and 1C ).
Attenuation of Hypoxia-Induced PH in VSMC-Specific ROCK2-Deficient Mice
Next, we performed an in vivo study, using the mouse model of hypoxia-induced PH in ROCK2 +/− mice and littermate controls (LM), both of which showed normal growth under physiological conditions. When compared with aortic VSMC from LM (LM VSMC), mRNA (reverse transcriptase-polymerase chain reaction) and protein (Western blotting) expressions of ROCK2 in aortic VSMC from ROCK2 +/− mice (ROCK2 +/− VSMC) were significantly reduced by 42% and 24%, respectively. In contrast, the expressions of ROCK1 in VSMC were comparable between the 2 genotypes (Figure IIIA-IIIE in the online-only Data Supplement). In addition, we confirmed that the protein expression of ROCK2 in the denuded aorta was reduced in ROCK2 +/− compared with LM mice ( Figure IIIF- was also significantly decreased to the same extent (417×10 3 versus 425×10 3 mm 3 , respectively; Table I in the online-only Data Supplement), and no difference in the pulmonary vasculature was noted between the 2 genotypes under normoxic conditions. Similarly, chronic hypoxia prevented the body weight gain to the same extent between the 2 genotypes ( Figure IVA in the online-only Data Supplement). Under normoxic conditions, right ventricular systolic pressure was comparable between the 2 genotypes. However, after hypoxic exposure, the elevation of RV systolic pressure was significantly suppressed in ROCK2 +/− compared with LM mice (Figure 2A ; Table 1 ). Although other RV hemodynamic parameters, such as RV end-diastolic pressure and peak rates of RV pressure development (RV dP/dt max) and relaxation (RV dP/dt min), were comparable between the 2 genotypes under normoxic conditions, hypoxia-induced increases in those parameters were also significantly suppressed in ROCK2 +/− than in LM mice ( Figure 2A ; Table 1 ). In contrast, there was no significant difference in heart rate, systemic blood pressure, or left ventricular hemodynamic parameters between the 2 genotypes before and after chronic hypoxia ( Table 1 ). The extent of RV hypertrophy, as measured by the ratio of RV/(left ventricle+septum [S]), was also significantly less in ROCK2 +/− compared with LM mice after chronic hypoxia ( Figure 2B ). Furthermore, histological analysis showed that the extent of hypoxia-induced pulmonary vascular remodeling was significantly suppressed in ROCK2 +/− compared with LM mice ( Figure 2C and 2D). The number of CD45-positive inflammatory cells in the hypoxic pulmonary artery was also significantly reduced in ROCK2 +/− compared with LM mice (Figure 2E and 2F). These results indicate that ROCK2 deficiency in VSMC ameliorates hypoxia-induced PH in mice in vivo.
Augmentation of Hypoxia-Induced PH in VSMC-Specific ROCK2-Overexpressing Mice
We then performed an in vivo study, using the mouse model of hypoxia-induced PH in ROCK2-Tg and wild-type littermate controls (CTL), both of which showed normal growth under physiological conditions. Protein expressions of ROCK2 in both VSMC and the whole aorta were significantly increased in ROCK2-Tg mice by 186% and 137%, respectively, with no changes in ROCK1 expression ( Figure VA , VB, VC, VF, VG, and VH in the online-only Data Supplement) compared with those of CTL mice. This was also the case for reverse transcriptase-polymerase chain reaction in VSMC ( Figure VD and VE in the online-only Data Supplement). Chronic hypoxia significantly increased hemoglobin concentration, decreased platelet count, and prevented body weight gain to the same extent in ROCK2-Tg and CTL mice ( Table II in Although all RV hemodynamic parameters were comparable between the 2 genotypes under normoxic conditions, hypoxiainduced increase in RV systolic pressure was significantly enhanced in ROCK2-Tg compared with CTL mice under hypoxic conditions ( Figure 3A ; Table 2 ). In contrast, there was no significant difference in heart rate, systemic blood pressure, or left ventricular hemodynamic parameters between the 2 genotypes before and after chronic hypoxia ( Table 2 ). The extent of hypoxia-induced RV hypertrophy, pulmonary vascular remodeling, and inflammation was significantly enhanced in ROCK2-Tg compared with CTL mice ( Figure 3B -3F).
These results indicate that ROCK2 overexpression in VSMC promotes hypoxia-induced PH in mice in vivo.
Role of ROCK2 in Hypoxia-Induced Pulmonary Vascular Cell Proliferation In Vivo
To further elucidate the mechanism of ROCK2-mediated development of hypoxia-induced PH in mice, we evaluated pulmonary vascular cell proliferation by immunostaining of Ki67 and P-ERK 1/2. The number of Ki67-positive cells was significantly reduced in ROCK2 +/− compared with LM mice ( Figure 4A and 4B ). Furthermore, immunostaining and Western blot of lung tissues showed that hypoxia-induced increase in ERK activity (ratio of P-ERK1/2 to total ERK1/2) in LM mice was significantly suppressed in ROCK2 +/− mice ( Figure 4C-4E) . Similarly, the whole ROCK activity (extent of phosphorylation of the myosin-binding subunit) of lung tissues was markedly increased in LM mice after chronic hypoxia and was significantly attenuated in ROCK2 +/− mice ( Figure 4D and 4F). In contrast, in ROCK2-Tg mice, the hypoxia-induced increases in the number of Ki67-positive cells and those in ERK and ROCK activities of lung tissues were significantly enhanced compared with CTL mice ( Figure 4G -4L). These results indicate that ROCK2 in PASMC contributes to the pathogenesis of hypoxia-induced PH, at least in part, through enhanced pulmonary vascular cell proliferation in vivo.
Role of ROCK2 in VSMC Proliferation and Migration In Vitro
VSMC proliferation and migration are typical characteristics of PH. 18 To further elucidate the role of ROCK2 in PAH, we performed cell proliferation and migration assay in vitro using the aortic VSMC cultured from each genotype of mice. VSMC proliferation, as measured by cell number in response to 10% or 0.1% fetal bovine serum, was significantly decreased in ROCK2 +/− compared with LM mice ( Figure 5A and 5B), whereas it was comparable between ROCK2-Tg and CTL mice ( Figure 5C and 5D ). In addition, to evaluate VSMC migration, we performed both scratch and a modified Boyden chamber assays. VSMC migration, as assessed by scratch assay in response to 0.1% fetal bovine serum, was significantly reduced in ROCK2 +/− mice ( Figure 5E and 5F) and was significantly enhanced in ROCK2-Tg mice ( Figure 5G and 5H) compared with respective littermates. Similar results were also obtained with a modified Boyden chamber assay in response to platelet-derived growth factor ( Figure 5I -5 L). Consistent with these findings, Western blot showed that ERK activity in VSMC after platelet-derived growth factor stimulation was significantly reduced in ROCK2 +/− mice, whereas it increased in ROCK2-Tg mice compared with respective littermates ( Figure VIA -VID in the online-only Data Supplement).
ROCK2-Induced Oxidative Stress and Inflammation in VSMC
To further elucidate the mechanism of VSMC proliferation, we performed analyses with VSMC from each genotype of mice (Figures VII and VIII in the online-only Data Supplement). First, we examined the expression of oxidative stress genes in VSMC because they play an important role in VSMC proliferation and PH development. 18 Inconsistent with the previous reports that ROCK contributes to oxidative stress induction in VSMC, the expression of NADPH oxidases (eg, NOX2 and NOX4) was lower in Rock2 +/than that in VSMC-specific heterozygous ROCK2-deficient mice (ROCK2 +/− ) and littermate control mice (LM) were exposed to room air (normoxia) or 10% oxygen (hypoxia) for 4 weeks. B, RV hypertrophy assessed by the ratio of RV weight to left ventricular (LV) plus septum (S) weight (RV/LV+S) after exposure to normoxia or hypoxia for 4 weeks (n=15 each). C, Representative serial sections of pulmonary arterioles stained with Elastica-Masson (EM) and with antibodies to α-smooth muscle actin (αSMA) exposed to normoxia or hypoxia for 4 weeks. Scale bars represent 100 μm (×40 magnification) and 25 μm (×400 magnification). D, Pulmonary vascular remodeling assessed by percentage medial wall thickness of pulmonary arterioles (n=6-8 each). E, Representative serial sections of pulmonary arterioles immunostained with antibodies to CD45 exposed to normoxia or hypoxia for 4 weeks. Scale bars=25 μm. F, The number of CD45-positive inflammatory cells per pulmonary arterioles (n=5 each). Results are expressed as mean±SEM. December 2013 expression of these NADPH oxidases was significantly higher in aortic VSMC from ROCK2-Tg mice (ROCK2-Tg VSMC) than in those from littermate control mice (CTL VSMC) under both normoxic and hypoxic conditions ( Figure VIIB and VIID in the online-only Data Supplement). Second, because heme oxygenase-1 (HO-1) is well-known to have protective effects against oxidative stress, we analyzed HO-1 mRNA expression in the same manner. HO-1 was significantly induced in Rock2 +/when compared with Rock2 +/+ VSMC under both normoxic and hypoxic conditions ( Figure VIIE in the onlineonly Data Supplement). In contrast, the expression of HO-1 was significantly less in ROCK2-Tg VSMC than that in CTL VSMC under normoxic conditions ( Figure VIIF in the onlineonly Data Supplement), suggesting that the HO-1 expression is specifically regulated by ROCK2 in VSMC. These data are consistent with the established role of HO-1 that inhibits VSMC proliferation. 19 Third, we performed analysis on the expression of adhesion molecule in these VSMC. Vascular cell adhesion molecule-1 was inhibited in Rock2 +/compared with Rock2 +/+ VSMC under both normoxic and hypoxic conditions ( Figure VIIG in the online-only Data Supplement). In contrast, the expression of vascular cell adhesion molecule-1 was significantly increased in ROCK2-Tg VSMC than that in CTL VSMC under both normoxic and hypoxic conditions ( Figure VIIH in the online-only Data Supplement), suggesting that the expression of vascular cell adhesion molecule-1 was strongly regulated by ROCK2 in VSMC. We further examined the secretion of inflammatory cytokines from VSMC in vitro. The levels of inflammatory cytokines (eg, interferon-γ and tumor necrosis factor-α) secreted by VSMC were significantly reduced in ROCK2 +/− VSMC and increased in ROCK2-Tg VSMC compared with control VSMC under both normoxic and hypoxic conditions ( Figure VIIIA -VIIID in the online-only Data Supplement). Because interferon-γ and tumor necrosis factor-α contribute to VSMC proliferation and migration, 20,21 ROCK2 may contribute to VSMC proliferation and migration through autocrine/paracrine mechanisms by secreting these cytokines.
Knockdown of ROCK2 in PASMC From a Patient With IPAH
Finally, to determine whether ROCK2 rather than ROCK1 plays important roles in human PAH, PASMCs were isolated from pulmonary arteries from a patient with IPAH (IPAH-PASMC) who underwent lung transplantation. We also examined the role of each ROCK isoform in those cells using small interfering RNA (siRNA) knockdown technique. Western blot showed that the transfection of ROCK1-and ROCK2-siRNA to IPAH-PASMC reduced the expression of each isoform by 70% and 81%, respectively, compared with control siRNA, without affecting the protein expression of another isoform ( Figure IXA in the online-only Data Supplement). Effective knockdown was also confirmed at mRNA level by reverse transcriptase-polymerase chain reaction ( Figure IXB -IXE in the online-only Data Supplement). Cell proliferation in response to 10% or 0.1% fetal bovine serum was significantly decreased in IPAH-PASMC transfected with ROCK2-and dual ROCK1/2-siRNA compared with control siRNA, whereas no such effect was noted with ROCK1-siRNA ( Figure 6A and 6B ). In contrast, cell migration, as assessed by scratch assay in response to 0.1% fetal bovine serum, was significantly reduced in IPAH-PASMC transfected with ROCK1-siRNA and those with ROCK2-siRNA to the same extent and was further suppressed in those with dual ROCK1/2-siRNA ( Figure 6C and 6D ). In addition, ROCK activity, as assessed by the ratio of phosphorylated myosin-binding subunit at thr853 but not at thr696 to total myosin-binding subunit, was significantly reduced in IPAH-PASMC transfected with ROCK1-, ROCK2-, and dual ROCK 1/2-siRNA compared with control siRNA (Figure 6E-6G ). Finally, ERK activity in response to platelet-derived growth factor stimulation was significantly reduced in IPAH-PASMC transfected with ROCK2-and dual ROCK1/2-siRNA compared with control siRNA (Figure 6H and 6I) . Taken together, these results indicate that ROCK2 rather than ROCK1 in human IPAH-PASMC mediates both cell proliferation and migration through ROCK activation and partially through ERK activation.
Discussion
The major findings of the present study are as follows: (1) the expression of ROCK2, but not ROCK1, was upregulated in the media of pulmonary arteries and PASMC from patients with IPAH; (2) ROCK2 in PASMC from mice was required for the development of hypoxia-induced PH; and (3) ROCK2 Results are expressed as mean±SEM. Comparisons were performed using 1-way ANOVA. LV dP/dt max indicates peak rates of left ventricular pressure development; LV dP/dt min, peak rates of LV pressure relaxation; LVEDP, LV enddiastolic pressure; LVSP, left ventricular systolic pressure; ROCK, Rho-kinase; RV dP/dt max, peak rates of right ventricular pressure development; RV dP/dt min, peak rates of RV pressure relaxation; RVEDP, RV end-diastolic pressure; RVSP, right ventricular systolic pressure; and VSMC, vascular smooth muscle cells. **P<0.01 vs normoxia in each group. †P<0.05. † †P<0.01 vs hypoxic LM mice. VSMC-specific ROCK2-overexpressing transgenic mice (ROCK2-Tg) and wild-type littermate control mice (CTL) were exposed to room air (normoxia) or 10% oxygen (hypoxia) for 4 weeks. B, RV hypertrophy assessed by the ratio of RV weight to left ventricular (LV) plus septum (S) weight (RV/LV+S) after exposure to normoxia or hypoxia for 4 weeks (n=15 each). C, Representative serial sections of pulmonary arterioles stained with Elastica-Masson (EM) and with antibodies to α-smooth muscle actin (αSMA) exposed to normoxia or hypoxia for 4 weeks. Scale bars represent 100 μm (×40 magnification) and 25 μm (×400 magnification). D, Pulmonary vascular remodeling assessed by percentage medial wall thickness of pulmonary arterioles (n=5-6 each). E, Representative serial sections of pulmonary arterioles immunostained with antibodies to CD45 exposed to normoxia or hypoxia for 4 weeks. Scale bars=25 μm. F, The number of CD45-positive inflammatory cells per pulmonary arterioles (n=5 each). Results are expressed as mean±SEM. December 2013 in IPAH-PASMC was also required for PASMC migration and proliferation. To the best of our knowledge, this is the first study that demonstrates that ROCK2 contributes to the pathogenesis of PAH, suggesting that ROCK2 is an important therapeutic target for the treatment of the disorder.
In the present study, we observed that ROCK2 expression was upregulated in pulmonary arterial media and PASMC from patients with IPAH compared with controls. Interestingly, it has been recently reported that the Rho/ROCK pathway enhances cancer progression and that upregulated ROCK2 levels are observed in esophageal, hepatocellular, colon, and bladder cancer. [22] [23] [24] [25] [26] Furthermore, a new concept has recently been proposed that the pathobiology of severe IPAH resembles that of cancers in humans. 27 In the present study, the ROCK2 upregulation in pulmonary arteries from patients with IPAH were associated with enhanced proliferation and migration of PASMC, similar to human cancer cells.
In the present study, we observed that the extent of hypoxiainduced PH was reduced in VSMC-specific ROCK2 +/− mice and was enhanced in VSMC-specific ROCK2-Tg mice. The SM22α promoter used for the generation of these mice is expressed in both VSMC and cardiac myocytes at early embryonic stages and finally becomes restricted to VSMC at late embryonic stages and throughout adulthood. 28 In addition, these mutant mice showed normal postnatal development with normal cardiac function (Tables 1 and 2 ). Thus, embryonic lethality observed in VSMC-specific ROCK2 −/− mice suggests that ROCK2 plays an essential role, especially in the development of blood vessels.
ROCK activation of the lung tissues from mice was observed in hypoxia-induced PH. We and other group have recently demonstrated a direct evidence for ROCK activation in patients with IPAH. 13, 29 Recent studies also reported that increased ROCK activity might be a biological marker for cardiovascular disease. [30] [31] [32] We observed that ROCK activity of the lung tissues after chronic hypoxia was reduced in ROCK2 +/− mice and was increased in ROCK2-Tg mice compared with respective littermates. Furthermore, similar results were obtained for ERK activity that is known to be important for VSMC migration and proliferation. [33] [34] [35] However, we observed less dramatic changes in ROCK and ERK activities compared with those in the degree of PH, which could be explained by the fact that we used whole mouse lung tissue for Western blot that contains not only VSMC but also many other types of cells. In addition, we confirmed that pulmonary arteries from patients with IPAH revealed enhanced ERK activity. Taken together, these results provide the first evidence that ROCK2 in VSMC mediates hypoxia-induced PH in mice through ROCK activation and partially through ERK activation.
We further examined the role of ROCK2 in the VSMC from each genotype of mice and human IPAH-PASMC in vitro. We found that both migration and proliferation were reduced in VSMC from ROCK2 +/− mice, as well as in human IPAH-PASMC transfected with ROCK2-siRNA. Furthermore, migration was enhanced in VSMC from ROCK2-Tg mice. As described above, ROCK2 overexpression was also observed in IPAH-PASMC, which has been reported to show phenotypically greater migration and proliferation than non-PAH-PASMC. 36, 37 Consistently, the expressions of NADPH oxidases (eg, NOX2 and NOX4), which contribute to the pathogenesis of PH, 38, 39 were significantly less in ROCK2 +/− VSMC and were enhanced in ROCK2-Tg VSMC. In contrast, the expression of HO-1 was significantly increased in ROCK2 +/− VSMC and less in ROCK2-Tg VSMC, which is supported by the observation that HO-1 ameliorated hypoxia-induced PH in mice. 40 Importantly, the expression of vascular cell adhesion molecule-1, which contributes to inflammatory cell migration, 20 was significantly less in ROCK2 +/− VSMC and increased in ROCK2-Tg VSMC. In addition, ROCK2 +/− VSMC secreted less inflammatory cytokines (eg, interferon-γ and tumor necrosis factor-α). 20, 21 In contrast, the secretion of these inflammatory cytokines was significantly increased in ROCK2-Tg VSMC. Taken together, we demonstrated that ROCK2 in VSMC may contribute to oxidative stress induction, resulting in VSMC proliferation, adhesion molecule expression, and inflammatory cytokines secretion ( Figure X in the online-only Data Supplement). We observed significant increase in the number of CD45-positive inflammatory cells in the lung tissue, which was significantly less in ROCK2 +/− mice and was significantly increased in ROCK2-Tg mice compared with the respective littermates (Figures 2E, 2F, 3E, 3F, 4A, 4B, 4G, and 4H) .
The secretion of inflammatory cytokines/chemokines and growth factors is regulated by oxidative stress in VSMC. 38 Hypoxia is thought to induce oxidative stress, 41 thereby Results are expressed as mean±SEM. Comparisons were performed using 1-way ANOVA. LV dP/dt max indicates peak rates of LV pressure development; LV dP/dt min, peak rates of LV pressure relaxation; LVEDP, left ventricular enddiastolic pressure; LVSP, left ventricular systolic pressure; ROCK, Rho-kinase; RV dP/dt max, peak rates of RV pressure development; RV dP/dt min, peak rates of RV pressure relaxation; RVEDP, right ventricular end-diastolic pressure; RVSP, right ventricular systolic pressure; and VSMC, vascular smooth muscle cells. **P<0.01 vs normoxia in each group. † †P<0.01 vs hypoxic CTL mice.
promoting VSMC proliferation, pulmonary vascular remodeling, and PH. 39, 42 Thus, the cooperative interaction between extracellular inflammatory cytokines and pulmonary vascular ROCK2 is critical for the process of hypoxia-induced PH. Therefore, these data support the idea that ROCK2 in VSMC may play a crucial role in the oxidative stress induction, VSMC proliferation, and the development of hypoxia-induced PH. Besides these results, it has been reported that the inhibition of ROCK2, rather than that of ROCK1, increased apoptosis and decreased contraction in VSMC, ameliorating vascular remodeling in PH. 16, 43 Pulmonary arterial endothelial dysfunction, as well as abnormal PASMC phenotype, contributes to the development of PAH. 3 We have previously reported that endothelium-dependent relaxation was significantly impaired in small pulmonary arteries isolated from patients with IPAH compared with controls. 13 Interestingly, it has recently been reported that ROCK2, rather than ROCK1, in endothelial cells contributed to angiogenesis and production of cell adhesion molecules, both of which are known to deteriorate PAH. 44, 45 All these observations indicate that ROCK2, rather than ROCK1, is a key regulator of multiple vascular cell functions, especially in VSMC, and could be an important therapeutic target of PAH.
The present findings confirm the importance of ROCK2 of PASMC in the pathogenesis of hypoxia-induced PAH both in vitro and in vivo. However, in some experimental models of PH, ROCK1 may also contribute to the development of PH. In fawn-hooded rats that develop severe PH even under mild hypoxia, ROCK1 expression of pulmonary arteries was increased and fasudil reduced the development of PH. 46 In monocrotaline-injected pneumonectomized rats that develop severe PH, ROCK1 expression of lung tissues was constitutively activated with ROCK activation. 47 In the present study, we also found that migration, but not proliferation, was reduced in IPAH-PASMC transfected with ROCK1-siRNA and was further suppressed with dual ROCK1/2-siRNA. Thus, ROCK1 might be involved, at least in part, in the pathogenesis of PAH through enhanced PASMC migration.
Several limitations should be mentioned for the present study. First, both ROCK2 +/− and ROCK2-Tg mice survived normally under normoxic conditions. It was previously shown that systemic homozygous ROCK2-deficient mice backcrossed into a C57BL/6 background have a low survival rate of <1%. 48 Thus, further studies are needed to determine whether ROCK2 abnormalities affect long-term survival. Second, no systemic or pulmonary hemodynamic abnormalities were noted in ROCK2 +/− mice under basal normoxic conditions. ROCK2, rather than ROCK1, seems to be essential for the regulation of arterial pressure because systemic heterozygous ROCK1deficient mice have normal basal blood pressure. 49 It is conceivable that in the present study, only a 24% reduction in ROCK2 protein expression in aortic VSMC may have no significant hemodynamic effects in ROCK2 +/− mice. Third, in the present study, we used mouse aortic VSMC, but not PASMC, because of technical reasons, although it is well-known that the effects of hypoxia on the aorta and systemic vessels have different features from those on the pulmonary circulation. Instead of using mouse PASMC, we performed mechanistic analyses using PASMC from a patient with IPAH. However, because both cultured VSMC and PASMC change their phenotype during passage, our results obtained in vitro might not directly reflect the in vivo results. Fourth, we were unable to adjust the extent of ROCK2 overexpression in mice with that of patients with IPAH. However, the extent of ROCK2 mRNA upregulation in human IPAH-PASMC (1.8-fold increase) was fairly comparable with that in VSMC from ROCK2-Tg mice (1.4-fold increase). Thus, we think that the present results have important clinical implications to better understand the role of ROCK2 in the pathogenesis of PAH. Fifth, although we conventionally evaluated VSMC proliferation using cell count analysis, other additional cell proliferation or apoptosis assays had better be performed. Instead, we assessed ROCK2induced oxidative stress and secretions of inflammatory cytokines, which contribute to VSMC proliferation. The present study has important clinical implications. We have previously reported that an isoform-nonspecific ROCK inhibitor, fasudil, abolishes increased vasoconstriction of pulmonary arteries from patients with IPAH. 13 We also have demonstrated that fasudil exerts acute and effective pulmonary vasodilator responses in patients with severe PAH. 50, 51 Furthermore, the present findings suggest that the beneficial effects of fasudil are mediated mainly by its suppression of ROCK2 with a resultant inhibition of PASMC proliferation and migration. Thus, we have started the clinical trial with an oral form of long-acting fasudil for the long-term treatment of patients with PAH to evaluate its effect on pulmonary hemodynamics and prognosis. In summary, the present study provides the first evidence that ROCK2 in VSMC contributes to the pathogenesis of PAH.
